The light-hearted debate, “Primary Cardiovascular Prevention with SGLT2 Inhibitors or GLP-1 Receptor Agonists: Are We Ready for Prime Time?” took place Monday during the 80th American Diabetes ...
Please provide your email address to receive an email when new articles are posted on . Most of the studies compared TNF inhibitors with non-TNF-inhibitor DMARDs. The results may indicate that ...
The vision of precision oncology entails a shift toward (semi)automated, data-driven workflows that guide treatment on the basis of an individual patient's clinical and molecular profile and leverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results